早期持续预防性低温对重型颅脑创伤患者神经结局的影响:POLAR随机临床试验
POLAR-RCT为多国多中心随机试验,纳入511例重型颅脑创伤患者,比较早期预防性低温(33-35°C)与常温管理对6个月神经结局的影响。
要点
- 早期预防性低温未改善重型颅脑创伤患者6个月神经结局。
- 低温组与常温组有利结局风险差0.4%(95%CI -9.4%至8.7%)。
- 两组肺炎与颅内出血增加发生率相近,安全性无显著差异。
核心结论
- 对重型颅脑创伤患者,早期预防性低温与常温管理相比未改善6个月神经结局。
- 研究结果不支持对重型颅脑创伤患者使用早期预防性低温。
研究设计与样本
- POLAR-RCT为多中心随机临床试验,在6个国家招募511例重型颅脑创伤患者。
- 266例随机至预防性低温组,245例至常温管理组。
- 低温目标33°C-35°C至少72小时,颅内压升高时延长至7天,随后缓慢复温。
- 常温目标37°C,必要时使用体表降温包裹,两组温度管理均7天。
- 主要结局为伤后6个月盲法评估的Glasgow结局扩展量表(GOS-E)评分5-8分。
主要发现
- 500例提供持续知情同意,平均年龄34.5岁(SD 13.4),402例(80.2%)为男性,466例完成主要结局评估。
- 低温在伤后中位1.8小时(IQR 1.0-2.7)内启动,复温中位时间22.5小时(IQR 16-27)。
- 6个月有利结局(GOS-E 5-8分)在低温组为117例(48.8%),常温组为111例(49.1%)。
- 肺炎发生率低温组55.0% vs 常温组51.3%,颅内出血增加发生率18.1% vs 15.4%。
临床怎么用
- 对于重型颅脑创伤患者,不应常规采用早期预防性低温以改善神经结局。
- 临床决策应基于现有证据权衡低温的潜在风险与获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: After severe traumatic brain injury, induction of prophylactic hypothermia has been suggested to be neuroprotective and improve long-term neurologic outcomes. OBJECTIVE: To determine the effectiveness of early prophylactic hypothermia compared with normothermic management of patients after severe traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS: The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury-Randomized Clinical Trial (POLAR-RCT) was a multicenter randomized trial in 6 countries that recruited 511 patients both out-of-hospital and in emergency departments after severe traumatic brain injury. The first patient was enrolled on December 5, 2010, and the last on November 10, 2017. The final date of follow-up was May 15, 2018. INTERVENTIONS: There were 266 patients randomized to the prophylactic hypothermia group and 245 to normothermic management. Prophylactic hypothermia targeted the early induction of hypothermia (33°C-35°C) for at least 72 hours and up to 7 days if intracranial pressures were elevated, followed by gradual rewarming. Normothermia targeted 37°C, using surface-cooling wraps when required. Temperature was managed in both groups for 7 days. All other care was at the discretion of the treating physician. MAIN OUTCOMES AND MEASURES: The primary outcome was favorable neurologic outcomes or independent living (Glasgow Outcome Scale-Extended score, 5-8 [scale range, 1-8]) obtained by blinded assessors 6 months after injury. RESULTS: Among 511 patients who were randomized, 500 provided ongoing consent (mean age, 34.5 years [SD, 13.4]; 402 men [80.2%]) and 466 completed the primary outcome evaluation. Hypothermia was initiated rapidly after injury (median, 1.8 hours [IQR, 1.0-2.7 hours]) and rewarming occurred slowly (median, 22.5 hours [IQR, 16-27 hours]). Favorable outcomes (Glasgow Outcome Scale-Extended score, 5-8) at 6 months occurred in 117 patients (48.8%) in the hypothermia group and 111 (49.1%) in the normothermia group (risk difference, 0.4% [95% CI, -9.4% to 8.7%]; relative risk with hypothermia, 0.99 [95% CI, 0.82-1.19]; P = .94). In the hypothermia and normothermia groups, the rates of pneumonia were 55.0% vs 51.3%, respectively, and rates of increased intracranial bleeding were 18.1% vs 15.4%, respectively. CONCLUSIONS AND RELEVANCE: Among patients with severe traumatic brain injury, early prophylactic hypothermia compared with normothermia did not improve neurologic outcomes at 6 months. These findings do not support the use of early prophylactic hypothermia for patients with severe traumatic brain injury. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00987688; Anzctr.org.au Identifier: ACTRN12609000764235.
引用
- Cooper DJ, Nichol AD, Bailey M, et al. Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial. JAMA. 2018. PMID: 30357266. doi:10.1001/jama.2018.17075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。